RATIONAL DRUG THERAPY FOR THE MANAGEMENT OF ASTHMA
AN INTERNSHIP BASED PROJECT AT MARDAN MEDICAL COMPLEX, MARDAN
By ZAWAR HUSSAIN Reg. No. PHR120091104 Doctor of Pharmacy (Pharm-D)
DEPARTMENT OF PHARMACY KOHAT UNIVERSITY OF SCIENCE AND TECHNOLOGY KOHAT, KHYBER PAKHTUN KHWA, PAKISTAN Session (2008-2013) CERTIFICATE OF APPROVAL
This project entitled RATIONAL DRUG THERAPY FOR THE MANAGEMENT OF ASTHMA in the Medical-A ward of Mardan Medical Complex, Mardan, prepared by ZAWAR HUSSAIN submitted to the Department of Pharmacy in the partial fulfillment of the requirements for the degree of Doctor of Pharmacy is hereby approved for submission.
SUPERVISOR: ___________________________ Mr.Ghayour Ahmed, Lecturer, Department of Pharmacy, KUST
INTERNAL EXAMINER: ___________________________ Mr.Ghayour Ahmed Lecturer, Department of pharmacy, KUST.
CHAIRMAN: ___________________________ Dr. Abdul Wahab Assistant Professor, Department of Pharmacy, KUST.
DEDI CATI ON I would like to dedicate this study to the Almighty Allah, to my beloved family specially to my father, to my friends and my relatives. I would also like to dedicate this project to my fellows who were & will be, very important part of my life.
ACKNOWLEDGMENT
I owe my deepest gratitude to Almighty ALLAH for He is the source of our strength and power. It is a pleasure to thanks those who made this thesis possible. I am deeply grateful to Ministry of Health and Dr. Abdul Wahab, Chairman Department of Pharmacy, Kohat University of Science & Technology for their struggles to arrange the Clinical Pharmacy clerkship in Government Teaching Hospitals.. I wish to express sincere gratitude to my supervisor Mr. Ghayour Ahmed who has supported me throughout my thesis with his patience and knowledge while allowing me the room to work in my own way. He has been the ideal thesis supervisor. His sage advice, insightful criticisms, and encouragement aided the writing of this thesis in innumerable ways. He has made available his support in a number of ways. I also thankful to my ALL Teachers, who ornaments & facilitate me with grate knowledge, during my university life. I would like to extend my warmest thanks to Ms. Bushra Khan, Chief Pharmacist Mardan Medical Complex, Mardan Where would I be without my family? It is an honor for me to take this opportunity to thank my affectionate, sympathetic and respectable father Mr. Muatabar Khan & my Mother who brought me up with their love; and Sister for their prayers and support throughout my career. My sincerest thanks to my brothers Mansoor Akhter and Asad Ali for their patience, assistance, continuous support and encouragement during the completion of this work. I would like to give my heartfelt appreciations to my best friends Shabab Hussain, M.Bilal and Amin ur Rahman for their friendly assistance and kind suggestions throughout the completion of this thesis. I pay A cordial thanks to my romates, best friends & everything for me, Salman Khan & Sajid Ali for being a special part of my university life. Last but not the least, thanks to Tauseef Ahmad, Shabih ul Hassan, Zia ullah, Sardar Ali, Tanveer Ahmad and All of my class fellows, J uniors and seniors for being an important part of my Universitys life. Thanks to all of my friends and everyone, who have been contributing by supporting my work, and helped me during the final year project. May ALLAH bless them all and give me the strength to serve the humanity. Aameen! Zawar Hussain Pharm-D CONNTENTS
TITLE
PAGE NO: List of abbreviations I List of figures III List of tables IV Summary V
ACRONYMES EIB Exercise Induced Bronchospasm ESBL Extended Spectrum Beta Lactamase PEF Peak Expiratory Flow IL Inter Leukins ICU Intensive Care Unit MDR Multi Drug Resistance NAEPP National Asthma Education and Prevention Program PAF Platelet Activating Factor SARS Severe Acute Respiratory Syndrome SaO2 Oxygen saturation IV Intravenous IM Intramuscular PaO2 Partial Pressure Of Oxygen In Arterial Blood T-HC T-helper Cell BHR Broncial Hyper Responsiveness SOB Shortness of breath HTN Hypertension LRTi Lower tract respiratory infection MOH Ministry of health TDM Therapeutic drug monitoring ADRs Adverse drug reactions COPD Chronic obstructive pulmonary disease & And
II
OD Once a day TSF Tea spoon full TDS Thrice in a day SoS Si opus sit (if needed) BiD Bis in die (twice a day) NB Nebulisation pt Patient M Male F Female
III
LIST OF TABLES
S. No: Name Of Table Page. No 01 Classification of severity of chronic stable asthma 06 02 Classification of severity of asthma exacerbations 07 03 Step wise approaches of managing asthma 12 04 Quick relief medication of asthma 18 05 Patients demographic data 90 06 Age wise distribution of patients 92 07 Frequency of drug related problems 93 08 Causes of hospitalization 95 09 Concurrent diseases 96 10 Occurrence of drug interactions 97
IV
LIST OF FIGURES S. No NAME OF FIGURE Page No. 01 Patients demographic data 91 02 Age wise distribution of patients 92 03 Frequency of drug related problems 94 04 Causes of hospitalization 95 05 Concurrent diseases 96 06 Occurrence of drug interactions 98
V
SUMMARY
Thesis report is based on Clinical Pharmacy Clerkship rotation, on the management of asthma, completed in Mardan Medical Complex, Mardan, KPK. The data of 15 patients was collected and analyzed. The treatment prescribed at hospital of individual patient was compared with the standard pharmacotherapy and analyzed for any untreated condition, improper drug selection ,drug interaction, adverse drug reaction, drug without indication, sub therapeutic or excessive dosing, and cost related problems The goals of asthma therapy are to minimize chronic symptoms that impair normal activity (including exercise), to prevent recurrent exacerbations, to minimize the need for emergency department visits or hospitalizations, and to maintain near-normal pulmonary function. During the clinical pharmacy clerkship, rational pharmacotherapy of the Asthma disease was the main focus. To record & analyze medication-histories (medications used before admission); to analyze pharmacotherapy provided in the hospital; to evaluate the outcomes; to identify drug related problems; to analyze their management and to report drug information/therapeutic-consultation or patient education and counseling that were provided during rotations. The treatment provided in the hospital was according to the standard protocol however, some drug related problems were detected which include excessive doses, drug-drug interactions, 28 (42%) total drugs interaction were count, most common drug interactions were b/w cefotaxime and furosemide, adverse drug reactions were 06 (9.09%), untreated conditions were 5 (7.57%) and Cost related problems. Due to maximum number of patients in hospital and lack of proper interaction and cooperation between health care professionals, the goal and vision of rational pharmacotherapy is still far away. In order to rationalize overall pharmacotherapy of individual patient, professional mutual interaction among physicians, pharmacists and nurses is required. The patient education, counseling and information are also important parameter so that patient can be provided with complete pharmaceutical care. Patient must be educated properly in order to increase the compliance level. Ministry of Health is required to provide cost effective drugs to the respective hospitals. Free of cost medicines should be distributed among the needy patients.
CHAPTER ONE INTRODUCTION
Chapter One I ntroduction
Page 1
1.1 INTRODUCTION The National Asthma Education and Prevention Program (NAEPP) define asthma as a chronic inflammatory disorder of the airways in which many cells and cellular elements play a role. In susceptible individuals, inflammation causes recurrent episodes of wheezing, breathlessness, chest tightness, and coughing. These episodes are usually associated with airflow obstruction that is often reversible either spontaneously or with treatment. The inflammation also causes an increase in bronchial hyper responsiveness (BHR) to a variety of stimuli. ( Kelly.W et al 2009)
Asthma violence almost all age will begin, but mostly occurs often in childhood. It is a disease that may be seen as repeated violence of breath lessness and wheezing, which alter in extent and price for each particular person. Someone whom can be carried out each hour, and each day. This disorder is attributable to swelling in the air tract in the voice and has effects on this level of responsiveness in the nerve endings within the air tract so that they are often excitable. Your assault, this covering in the parts provides the air tract enlarge and minimizes circulation of fresh air in and from voice. (www.who.int) 1.2 ETIOLOGY Asthma is in the very least the partially heritable complex syndrome that will require the gene- byenvironment connection intended for phenotypic term. Environmentally, friendly risk variables for the improvement of asthma include things like socioeconomic rank, family members measurement, along with exposure to used cigarette smoke in childhood along with in utero, allergen publicity, urbanization, along with lowered exposure to frequent childhood infectious providers. Possibility variables intended for beginning (<3 years of age) recurrent wheezing regarding virus-like attacks include things like small delivery bodyweight, guy gender, along with parental smoking. On the other hand, that beginning style is a result of smaller airways, along with these kind of danger variables are certainly not automatically danger variables intended for asthma in the future. (Kelly. W et al 2008)
Chapter One I ntroduction
Page 2
1.3 SIGNS & SYMPTOMS The characteristic signs and symptoms of asthma is: Difficulty in breath (Shortness of breath) Chest pain or chest tight ness Wheezing Coughing
From the lungs may be sputum produced but it is hard to bring them out. During the recovery from the 1 st , when the sputum is bring out, its look white, due to high number of white blood cells, eosinophils in it. At the morning an also at the night the symptoms are severe or response to cold air or exercise. Some people rarely experience the symptoms, usually it is due to the response of triggers, where many people have persistent and marked symptoms. (Ronald. G et al 2005)
1.4 PREVELANCE OF ASTHMA As of 2011 235-330 million people were affected of asthma worldwide. 250,000-345,000 People die annually from the asthma worldwide, different countries have different rates. It is more common in developed countries than in developing countries. Asthma is same common to males and females. (www.who.int) In Pakistan nearly 20 million person have asthma. It is the 12% of the adult population that is suffering from Pakistan. (www.lahorerealestate.com)
1.5 PATHOPHYSIOLOGY Asthma gets the significant trait include bronchial hyper responsiveness, airway redness along with a variable amount of air movement obstruction (related to bronchospasm, edema, as well as hypersecretion). Inhaled things that trigger allergies bring about a great early-phase hypersensitive reaction seen as a activation of cellular material bearing allergen-specific immunoglobulin Electronic (IgE) antibodies. There exists fast activation of airway mast cellular material as well as macrophages, which usually generate pro-inflammatory mediators such as histamines as well as eicosanoids that creates contraction of airway smooth muscle mass, mucus release, vasodilation, as well as exudation of plasma inside the airways. Plasma healthy proteins Chapter One I ntroduction
Page 3
leakage induces a new thickened, engorged, edematous airway wall membrane along with a narrowing with the airway lumen using decreased mucus clearance. The particular late-phase inflammatory effect occurs 6-9 hours following allergen provocation along with entails recruitment along with activation associated with eosinophils, basophils, T- lymphocytes neutrophils, along with macrophages. This migration, associated with eosinophils occurs to airways along with inflammatory mediators (leukotrine along with granule proteins), cytokines, along with cytotoxic mediators usually are secretes. Your generate associated with cytokines occurs with the activation associated with T-lymphocyte, through variety two T-helper (TH2) solar cells of which mediate sensitive redness (interleukin [IL]-4, IL-5, along with IL-13). On the other hand, variety 1 T-helper (TH1) solar cells generate IL two along with interferon- which might be needed for mobile immune system. A great disproportion involving TH1 along swith TH2 solar cells may well final results Allergic asthma suffering redness. Your generate associated with mediators such as histamine; eosinophils, along with neutrophils chemo strategy variables; leukotrines C4, D4, along with E4; prostaglandins, along with platelet-activating issue (PAF) final results due to mast cell degranulation in a reaction to contaminants in the air. Histamine can be able to inducting even muscle mass constriction along with bronchospasm and may even play a role in mucosal edema along with mucus release. Alveolar macrophages generate quite a few inflammatory mediators including PAF along with leukotrienes B4, C4, along with D4. Manufacturing associated with neutrophil chemotactic issue along with eosinophil chemotactic issue furthers this inflammatory procedure. Neutrophils will also be a new way to obtain mediators (PAFs, prostaglandins, thromboxanes, along with leukotrienes) of which give rise to BHR along with air passage redness. Your 5-lipoxygenase path associated with arachidonic acid solution fat burning capacity is in charge of output associated with cysteinyl leukotrienes. Leukotrienes C4, D4, along with E4 usually are introduced throughout inflammatory techniques inside lung along with generate bronchospasm, mucus release, microvascular permeability, along with air passage edema. Bronchial epithelial solar cells engage in Infection simply by delivering eicosanoids, peptidases, matrix proteins, cytokines, along with nitric oxide. Epithelial dropping ends in raised air passage responsiveness improved Permeability of the air passage mucosa, lacking associated with epithelial-derived enjoyable variables, along with Loss of digestive support enzymes liable for degrading inflammatory neuropeptides. Chapter One I ntroduction
Page 4
Your exudative inflammatory procedure along with sloughing associated with epithelial solar cells in to the air passage Lumen affects mucociliary transfer. Your bronchial glands usually are improved in space, along with thegoblet solar cells usually are improved in space along with number. Expectorated mucus through sufferers along with asthma tends to have high viscosity. Your air passage can be innervated simply by parasympathetic, sympathetic, along with neo adrenergic inhibitory anxious feelings. The normal slumbering firmness associated with air passage even muscle mass can be looked after simply by vagal efferent activity, along with bronchoconstriction can be mediated simply by vagal excitement inside small bronchi. Air passage even muscle mass is made up of neo innervated 2-adrenergic receptors of which generate bronchodilators. Your neo adrenergic, neo cholinergic tense method inside trachea along with bronchi may well increase redness in asthma simply by delivering nitric oxide. (Kelly. W at al 2009)
List of agents and events triggering asthma Breathing contamination: Breathing syncytial virus (RSV), rhinovirus, influenza, parainfluenza, Mycoplasma Pneumonia. Contaminants in the air: Airborne pollens (grass, timber, weeds) house-dust mites, pet danders, cockroaches, fungal spores. Atmosphere: Cold air flow, fog, ozone, sulphur dioxide, nitrogen dioxide, tobacco light up, wooden light up. Inner thoughts: Stress, strain, fun. Exercising: Particularly throughout cool, dried up local climate. Drugs/preservatives: Aspirin, non-steroidal, anti-inflammatory drugs (cyclooxygenase inhibitors), sulphides, benzalkonium chloride, nonselective -blockers.
Occupational stimuli: Bakers (flour dust); farmers (hay mold); liven along with enzyme individuals; ink jet printers (Arabic gum); Chemical industry individuals (azo inorganic dyes, anthraquinone, ethylenediamine, toluene diisocyanates, polyvinyl chloride); pouches, rubberized, along with wooden individuals (formaldehyde, American forest, dimethylethanolamine, anhydrides. (Kelly. W et al 2008) Chapter One I ntroduction
Page 5
1.6 CLINICAL PRESENTATION CHRONIC ASTHMA Classic asthma is usually seen as an episodic dyspnea along with wheezing, though the Specialized medical presentation involving asthma is usually diverse. Individuals have complaint Dyspenia episodes, tightness of chest, and coughing (particularly on night), wheezing, or maybe a whistling seem any time during breathing. These often take place using exercising however may possibly take place spontaneously or even in association with the known things that trigger allergies. Signs include expiratory wheezing on auscultation, dry out hacking cough or even symptoms involving atopy (e. g., allergic rhinitis or even eczema). Asthma may differ from chronic day-to-day signs and symptoms to be able to just spotty signs and symptoms. This intervals in between signs and symptoms are from days to weeks, several weeks, or even a long time. This seriousness is determined by lung operate, signs and symptoms, night time awakenings, in addition to disturbance using normal activity ahead from the therapy. Individuals can easily existing using mild spotty signs and symptoms that want simply no medicinal drugs or even just irregular by using short-acting inhaled 2-agonists, in the severe chronic conditions the individuals may receive multiple medications. (Kelly. W et al 2009)
ACUTE SEVERE ASTHMA Out of control asthma can advance a great serious condition wherever inflammation, airway edema, increased mucus piling up and also serious bronchospasm bring about profound airway narrowing that is certainly the wrong way attentive to usual bronchodilator therapies. Patients can be restless inside serious hardship and also protest of serious dyspnea, shortness of breath, chest tightness as well as burning. Symptoms are generally unresponsive to usual actions. Symptoms consist of expiratory and also inspiratory wheezing in auscultation, dry cough, tachypnea, Tachycardia, pallor as well as cyanosis, and also hyper inflammed chest muscles together with intercostal and also supraclavicular retractions. Air sounds can be diminished together with extremely serious blockage. (Kelly. W et al 2009) Affected individual is able to say only some phrases devoid of ending to adopt any breathing. Misunderstandings, lethargy, and blue skin (cyanosis) are the signals that how the persons breathable oxygen significantly restricted, along with crisis remedy is necessary. Generally, a Chapter One I ntroduction
Page 6
patient recovers completely having proper remedy, also at a severe asthma attack. (www.merckmanuals.com)
1.7 CLASSIFICATION OF ASTHMA SEVERITY The classification system is developed by NAEPP which might be beneficial throughout guiding asthma therapy and also determining sufferers on high-risk pertaining to building life-threatening asthma attacks. Table 1.1 is employed to help classify this extent connected with chronic, stable asthma; table 1.2 is employed to help classify the extent connected with asthma exacerbations. A Patients scientific capabilities previous to treatment are employed to help classify the patient. This occurrence connected with solely among the extent capabilities is sufficient to use the patient in this clasification; sufferers should be issued for the most severe level by which just about any characteristic happens. ( Chessnutt. M et al 2006)
Chapter One I ntroduction
Page 7
1.8 DIAGNOSIS Any time asthma is suspected from scientific capabilities and other diseases have been regarded and ruled out (e.g. tumors within grownups, foreign body within children; dont believe the particular existence regarding wheeze implies asthma), confirm the particular diagnosis by simply target methods regarding variable airflow impediment as well as asss severity. Generally the subsequent criteria might suffice since target evidence of variable circulation obstruction:
Chapter One I ntroduction
Page 8
Spirometery: o A 12 % or greater improvement in forced expiratory volume (FEV1) in children and adults, and more than 200ml in adults from the baselines 15 minutes after use of an inhaled short acting beta 2 agonist. o PEF- Serial measures of peak expiratory flow (PEF): A more than 20 % change after administration of a bronchodilator in asthmatic patient. When there is some probability of asthma and above test are non- diagnostic, the following tests may be used in the diagnosis of asthma: o Methacoline challenge o Exercise challenge o Inhaled corticosteroid trial: appropriate doses of inhaled steroids for 4-6 weeks.. (www.bcguidelines.c0m) The particular medical diagnosis of asthma is a professional medical one particular; there is absolutely no standardized classification with the sort, severity or perhaps frequency of symptoms, none with the results with exploration. The particular lack of a gold regular classification means that isn't achievable to generate distinct evidence primarily based endorsement with making an analysis of asthma. ( Thoracic. B 2009) Core to all explanations is the reputation associated with signs (more than certainly one of wheeze, breathlessness, chest tightness, cough and also associated with varying ventilation impediment). Modern account associated with asthma with young children and also older people have involved respiratory tract hyper responsiveness and also respiratory tract irritation because component of the sickness. Precisely how these functions relate to every single other people, the way they are usually finest tested and also the way they bring about the particular medical manifestation associated with asthma remains unclear. ( Thoracic. B 2009)
Making Diagnosis in Children: Initial Clinical Assessment: The diagnose of asthma is recognizing a characteristic pattern of episodic respiratory sign and symptoms. ( Thoracic. B 2009)
Chapter One I ntroduction
Page 9
Clinical features that increase the probability of Asthma The symptoms more than one: cough, wheeze, difficulty in breath, tightness of chest, particularly if these symptoms; Are recurrent and frequent Are worst at the early and night time occur in response to, are worse after, exercise or other triggers, such as exposure to pets, cold or damp air, or with emotions or laughter Occur apart from cold: Personal history of atopic disorder Family history of atopic disorder and/or asthma Widespread wheeze heard on auscultation History of improvement in symptoms of lung function in response to adequate therapy. ( Thoracic. B 2009) Clinical features that lower the probability of Asthma Symptoms with cold only, with no interval symptoms Isolated cough in the presence of wheeze or difficulty breathing History of moist cough No response to a trial of asthma therapy Normal peak expiratory flow (PEF) or spirometery when symptomatic Clinical features pointing to alternative diagnosis. ( Thoracic. B 2009) 1.9 DESIRE OUTCOME CHRONIC ASTHMA: The NAEPP provides the following goals for chronic asthma management: Reducing impairment: (1) Stop persistent and difficult signs and symptoms (e. grams., breathing problems or even breathlessness within the day time, in the evening, or even soon after exertion); Chapter One I ntroduction
Page 10
(2) Involve infrequent use (2 days/wk) regarding inhaled short-acting 2-agonist regarding speedy relief regarding signs and symptoms (not including deterrence regarding exercise-induced bronchospasm [EIB]). (3) Preserve (near-) standard pulmonary functionality; (4) Preserve standard activity degrees (including exercise and attendance at the office or even school); (5) Meet up with patients and families requirement regarding and satisfaction after due thought. (Kelly. W et al 2009)
Reducing risk: (1) Prevent recurrent exacerbations and lessen the importance regarding goes to as well as hospitalizations; (2) Prevent decrease in lung operate; regarding children, avoid reduced lung progress; (3) Little as well as absolutely no adverse effects associated with remedy. (Kelly. W et al 2009) ACUTE SEVERE ASTHMA: The aims regarding treatment method include things like: (1) Static correction regarding substantial hypoxemia; (2) Rapid letting go regarding throat blockage (within minutes) along with; (3) Decrease regarding the possibilities of recurrence regarding extreme air flow blockage. (Kelly. W et al 2009)
1.10 STANDARD TREATMENT GUIDELINES 1.10.1 NON PHARMACOLOGIC THERAPY: Sufferer education and also the instructing involving self-management ability ought to be the essence from the cure. Self-management plans increase adherence to help treatment sessions, self-management ability, in addition to use of professional medical services. Objective proportions involving circulation impediment which has a property maximum circulation meter might not automatically increase affected person effects. Your National Asthma Education and Prevention program (NAEPP) supporters use of Top expiratory circulation (PEF) monitoring only for patients having severe lingering asthma who have trouble perceiving air passage impediment. Chapter One I ntroduction
Page 11
Deterrence involving acknowledged allergenic triggers may increase signs, lower treatment work with, in addition to minimize Bronchial hyper responsiveness (BHR). Environmental triggers (e. g., animals) should be avoided throughout hypersensitive patients, and people whom smoking should be prompted to quit. Sufferers having acute severe asthma really should obtain extra O2 remedy to help keep arterial O2 vividness earlier mentioned 90%. Important dehydration should be remedied; urine distinct gravity can help guidebook remedy throughout small children, throughout whom analysis involving hydration rank might be difficult. (Kelly. W et al 2009)
1.10.2 PHARMACOTHERAPY: o Approach to Long-Term Treatment: The actual aims connected with asthma treatment tend to be to minimize continual signs or symptoms that damage regular task (including exercise), to avoid repeated exacerbations, to minimize the necessity pertaining to emergency team trips or perhaps hospitalizations, and to sustain near-normal pulmonary operate. These kinds of aims must be fulfilled while supplying best pharmacotherapy with all the fewest adverse effects although assembly individuals and also family members expectations connected with pleasure together with asthma care. Latest strategies to prolonged asthma concentrate on everyday anti-inflammatory treatment together with inhaled corticosteroids. Treatment method algorithms use both seriousness of your person's baseline asthma along with the seriousness connected with asthma exacerbations. The amount of prescription medication and also regularity connected with dosing tend to be determined through asthma seriousness and also focused toward suppression connected with growing air passage swelling. To ascertain fast management, treatment must be caused earlier for a greater power amount compared to anticipate pertaining to long-term treatment. Pharmacotherapy will then end up being cautiously set foot lower when asthma management is usually attained and also sustained; this will give pertaining to id from the lowest prescription medication important to sustain long-term management. (Chessnutt. M et al 2006)
o Pharmacologic Agents for Asthma Asthma prescribed drugs might be separated directly into a couple of categories: agents that provide quick reduction regarding symptoms along with agents delivered to showcase long-term Chapter One I ntroduction
Page 12
asthma handle. Quick-relief prescription drugs tend to be delivered to showcase immediate reversal regarding serious ventilation blockage along with relieve enclosed symptoms by simply immediate peace regarding bronchial even muscle. Long-term handle prescription drugs tend to be consumed everyday independent regarding symptoms to achieve and observe after handle regarding chronic asthma. These types of agents also called preservation, controller, or maybe preventative prescription drugs work largely to attenuate neck muscles redness. A lot of asthma prescription drugs tend to be applied orally or maybe by simply inhalation. Breathing associated with an correct real estate agent leads to an increasingly swift attack regarding pulmonary consequences in addition to fewer systemic consequences in comparison with common supervision with the very same dose. Metered-dose inhalers (MDIs) propelled by simply chlorofluorocarbons (CFCs) are actually the preferred shipping program. (Chessnutt. M et al 2006)
Chapter One I ntroduction
Page 13
Chapter One I ntroduction
Page 14
A. LONG-TERM CONTROL MEDICATIONS Anti-inflammatory agents, long-acting bronchodilators, in addition to leukotriene modifiers encompass the important medicinal drugs within this number of agents (see table: 1. 7). Other instructional classes involving agents are usually pointed out temporarily down below.
1. Anti-inflammatory agents Corticosteroids shows great, powerful and also prolong effect on pain relieving and also shows anti- inflammatory action. These people minimize equally serious and also serious infection, contributing to fewer asthma indicators, progress with airflow, decreased throat hyperresponsiveness, fewer asthma exacerbations, and also a smaller amount throat redecorating. These kinds of providers can also potentiate this activity connected with -adrenergic agonists. Inhaled corticosteroids are usually preferred for that long-term command connected with asthma and they are firstline providers with regard to patients along with persistent asthma. People along with persistent indicators or maybe asthma exacerbations who definitely are certainly not taking inhaled corticosteroids needs to be commenced when using inhaled corticosteroid; symptomatic patients currently taking a great inhaled corticosteroid needs this dosage greater. Chapter One I ntroduction
Page 15
Systemic corticosteroids (oral or maybe parenteral) are usually most effective with attaining immediate command connected with asthma while in exacerbations or maybe any time beginning long-term asthma treatment. Throughout patients along with significant persistent asthma, systemic corticosteroids tend to be required for this long-term suppression connected with indicators. Duplicated attempts needs to be built to reduce the dosage towards the minimum amount needed to command indicators. Alternate-day remedy is preferred to help regular remedy. Fast discontinuation connected with systemic corticosteroids after serious work with may well precipitate adrenal deficiency. Contingency remedy along with supplements and also vitamin supplements Deborah needs to be opened up to avoid corticosteroid-induced bone vitamin burning with long term administration. (Williams. L et al 2009)
2. Long-acting bronchodilators a. Mediator inhibitors: Cromolyn sodium along with nedocromil tend to be long-term handle medicines in which avoid asthma signs along with enhance air passage function throughout people with minor lingering asthma or even exercise-induced asthma. Payday cash brokers modulate mast mobile or portable mediator launch along with eosinophil recruitment along with inhibit each first along with delayed asthma suffering answers to help allergen challenge along with exercise-induced bronchospasm. The actual scientific a reaction to these kind of brokers can be fewer expected as opposed to a reaction to inhaled corticosteroids. Nedocromil may help slow up the measure prerequisites for inhaled corticosteroids. Each brokers get exceptional protection single profiles.. (Williams. l et al 2009) b. -Adrenergic agents: Long-acting 2-agonists present bronchodilation for as much as 12 hrs after having a single measure. Nonetheless, since his or her attack of actions will be overdue, these are definitely not powerful and also must not be found in the treating serious bronchoconstriction. (Williams. l et al 2009) c. Phosphodiesterase inhibitors: Theophylline delivers moderate bronchodilation within asthmatic people. This specific substance also can get anti-inflammatory qualities, improve mucociliary clearance, in addition to reinforce diaphragmatic contractility. Sustained-release theophylline preparations work well within preventing nocturnal asthma and they are typically appropriated for utilize since adjuvant therapies within people together with mild or perhaps severe chronic asthma. Many people could also be used since choice long-term preventive Chapter One I ntroduction
Page 16
therapies within people together with moderate chronic asthma. Theophylline serum conc. ought to be supervised directly due to the particular drug's slim deadly healing selection, personal dissimilarities within metabolism, along with the effects of many elements upon substance absorption in addition to metabolism. (Williams. l et al 2009)
3. Leukotriene modifiers This can be a hottest course associated with medicines with regard to long-term handle associated with asthma. Leukotrienes tend to be efficient biochemical mediators that contribute to neck muscles blockage in addition to asthma signs or symptoms by simply getting neck muscles clean muscle tissue, escalating vascular permeability in addition to mucus secretion, in addition to attracting in addition to activating neck muscles inflammatory cellular material. Zileuton is really a 5- lipoxygenase inhibitor that diminishes leukotriene generation, in addition to zafirlukast in addition to montelukast tend to be cysteinyl leukotriene receptor antagonists. That they bring about moderate advancements throughout lung perform in addition to reductions throughout asthma signs or symptoms. Most of these real estate agents can be regarded as solutions to help low-dose inhaled corticosteroids throughout affected individuals together with mild chronic asthma. Zileuton increase the amount of aminotransferase in plasma reversibly. (Williams. L et al 2009)
4. Miscellaneous agents By mouth sustained-release 2agonists usually are earmarked pertaining to patients using bothersome evening time asthma signs and symptoms as well as average to be able to serious persistent asthma which the other therapies usually dont give the response. Omalizumab is really a recombinant antibody that will binds IgE without activating mast cellular material. Inside clinical studies, the idea minimizes the importance pertaining to corticosteroids inside average to be able to serious asthma suffering patients using improved IgE levels. Corticosteroid-sparing anti-inflammatory agencies such as troleandomycin, methotrexate, cyclosporine, 4 immunoglobulin, and gold should be employed only inside decided on serious asthma suffering patients. These kind of and also other agencies include adjustable benefit and a concern toxicities. (Williams. l et al 2009)
Chapter One I ntroduction
Page 17
B. QUICK-RELIEF MEDICATIONS The quick relief medications for asthma are the important medication in Antiasthmatics, which includes;
Short acting Bronchodilators, and Systemic corticosteroids. (BNF for children. 2009)
Chapter One I ntroduction
Page 18
Chapter One I ntroduction
Page 19
1.11 AIMS AND OBJECTIVES
The aims and objectives of this clerkship are: Screening of Prescription for potential drug related problems. Estimate the frequency of drug related problems. Optimize rationality of prescriptions. Identify patient risk factors for drug related problems. To interpret, describe and apply the knowledge of pathophysiology and Therapeutics, based on diseases. Compliance monitoring. To obtain information from the patients and healthcare professionals to ensure Appropriate pharmacotherapy. To know about the effect of drug related problem on treatment cost. To compare the standard treatment guidelines with hospital treatment. To resolve the actual drug related problems. The main purpose of conducting clinical pharmacy training project is to rationalize drug therapy and ensure safe and appropriate and cost medicines. To determine drug use is a problem with management and prevention to improve the results of treatment. The World Health Organization defines rational use of drugs, "the judicious use of drugs requires that patients receive medications appropriate to their clinical needs, in doses that meet their individual needs for an appropriate period of time at the lowest cost to them and their community.
CHAPTER TWO METHODOLOGY
Chapter Two Methodology
Page 20
2.1 METHODOLOGY The study was comprised of 12 weeks duration and considering 15 cases of Asthma at Government Post Graduate Medical Institute Mardan Medical Complex Mardan. The proforma used for data collection included the following information; (1). Patient Information: This portion of the data collection form shows some characteristic of the patient like; name, gender, age, area, pregnancy and lactation status, occupation and living conditions. Importance: It provides useful information for the physician, pharmacist all health professionals as well as the attendants of the patient which distinguish certain patient from other patients. It helps out to dispense appropriate, inappropriate and correct dose and dosage form. It also helps in forensic and legal purposes. (2). Chief Complaints: These are the clinical features or symptoms which are mentioned by the patient in his/her own wordings/language due to which patient visit their physicians and patient are further treated which is based on these sign of the patient. Importance: It shows the reason for which the patient has come to the physician. It provides data why patient is admitted to a certain ward. It provides clue for the physician about the diagnosis of specific disease. (3). History of Present Illness: This is a brief discussion of the patients symptoms which is reported by the physician in their own medical language. Importance: It provides brief information about the anatomical location, nature of onset, severity and duration of disease. (4). Past Medical History: The past medical history includes information about any serious disease that the patient has experienced in the past and any previous hospitalization. Importance: It provides information about the final diagnosis of the patient if he had faced such type of symptoms in the past. Chapter Two Methodology
Page 21
(5). Past Surgical History: This portion includes information about surgical procedures. Importance: It provides information about the co-morbid conditions of the specific surgical procedure. (6). Social History: It includes the living status/behavior, occupation, economical status, education status, social drug use and physical activities. Importance: It may be helpful to identify the source of the disease. (7). Personal History: It provides information about personal daily routine like bowel habits, sleep, regularity of meal and marital status. Importance: It provides information about individual routine with the disease status. (8). Medication History: This portion includes all the medications/ medicines prescribed during the previous hospitalization. Importance: It provides information between the previous medications prescribed and current medications. (9)Laboratory Data: This portion of the data collection form includes all the tests performed by the patient for the finding of the disease status. Importance: It provides information in the confirmation of final diagnosis of the disease. (10). DRUG RELATED PROBLEMS (DRPs): (10.1). Untreated Condition(s): It is any type of the disease condition or manifestation among the chief complaints of the patient for which no drug is prescribed by the Physician. (10.2). Drug(s) without Indication: The drugs prescribed for which no pathological condition is present among the complaints of the patient is called drug without indication. (10.3). Improper Drug Selection: The drug prescribed to treat a particular health problem is not the drug of choice for that problem. Chapter Two Methodology
Page 22
(10.4). Sub-therapeutic dosage: It is the amount or strength of the drug prescribed that lies below the minimum therapeutic dose and fails to produce the desired therapeutic effect. (10.5). Excessive Dose: It is the quantity of a drug prescribed above the therapeutic dose which produces harmful/ untoward effects. (10.6). Improper Duration: When the drug is prescribed unnecessarily for a long or short period of time instead of the recommended duration for a specific disease. (10.7). Drug Interaction: Modification or alteration of the action/ effect of a drug in the body due to the presence of another drug, food, herbal, drink or an environmental chemical agent is called drug interaction. The drug interactions may lead to: 1. Synergism or additive effect. 2. Antagonism 3. Alteration of the effects of one or more drugs or production of idiosyncratic effects. (10.8). Inappropriate Dosage Form: It is the prescription of wrong dosage form instead of the correct and appropriate dosage form which may give rise to adverse drug reactions. (10.9). Cost related Problems: It is the prescription of high cost drugs instead of cost effective and good standard drug.. (10.10). Non-compliance: A state in which the patient fails to follow the instructions of the physician about drug use either accidentally or willingly. (11). Requiring Dose Adjustment in Hepatic Impairment: Liver plays a major role in the biotransformation and then excretion of drugs. In case of hepatic diseases/ impairment the adverse effects of these drugs appear rapidly therefore needs dose adjustment and proper monitoring of the patient. (12). Requiring Dose Adjustment in Renal Impairment: Kidney is the most important organ for excretion of drugs. In renal diseases/ impairment the excretion of drugs is reduced which leads to appearance of adverse effects of these drugs therefore needs dose adjustment and proper monitoring of the patient. Chapter Two Methodology
Page 23
(13). Therapeutic Duplication: When two or more drugs with the same effect or formula are prescribed for a certain condition at the same time is called therapeutic duplication. The side effects may be intensified.
Consultant/ Physician: Ward and admission No: B. No:
Admission date: Interview date:
Chief Complaints: ______________________________________________________________________________ ______________________________________________________________________________ ______________________________________________________________________________ ______________________________________________________________________________ ______________________________________________________________________________ ______________________________________________________________________________ _______________________ Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE
Diagnosis: ______________________________________________________________________________ __________________________________________________________________ Chapter Two Methodology
Page 25
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist
Chapter Two Methodology
Page 26
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: _____________________________________________________________________________________________________________________ ___________________________________________________________________________________________________ ________________________________________________________________________ Non-prescribed medication, if any: ______________________________________________________________________________ ______________________________________________________________________________ ____________________________________________________________ Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mention disease) _______________________________________________________________________ ______________________________________________________________________________ ______________________________________________________________ Do you have any other concurrent ailment / disease? ______________________________________________________________________________ _____________________________________________________________ Previous Surgery, if any? (Mention date/ year) ______________________________________________________________________________ _________________________________________________________ Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) ____________________________________________________________________________________________________________
What have you been told about your medicine and by whom? ______________________________________________________________________________ _____ Side effects / adverse effects, if any:
Patients Compliance: 1. How do you remember to take your medication? ______________________________________________________________________________ _______ 2. What do you do when you miss a dose? ______________________________________________________________________________ _______ Drug Interactions, if any: ______________________________________________________________________________ ______________________________________________________________________________ ______________________________________________________________________________ ____________________________________________________
Comments and recommendations (You may attach another sheet):
Consultant/ Physician: Dr.Shams ur rahman B. No: 5
Admission date: 12/03/2014 Interview date: 14/03/2014 Chief Complaints: Shortness of Breath Continues Cough Pulse: 72/min B.P: 140/9 mm of Hg Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 12/03/2014 HiB 12.5 mg/dl 14-16 mg/dl 12/03/2014 TLC 32600/ul 4000-11000/ul 12/03/2014 DLC: Ploys 85% 40- 75% 12/03/2014 Lampho 10% 20-45% 12/03/2014 Meno 03% 0-6% 12/03/2014 Esono 02% 0.6-1.2 Diagnosis: Asthma Chapter Two Methodology
Page 29
COPD Recurrent CVA Core-Pelmonale
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 12/03/2014 Inj.Astexone-1gm Cefotaxime OD
12/03/2014 Inj.Klaricid-500 mg in 100 ml Pladix Clarithromycin BiD
12/03/2014 O2 inhalation Pure Oxygen BiD
12/03/2014 Ventolin NB Solbutamol QiD
12/03/2014 Inj.Lasix-40 mg Furosemide State then OD
Complaints about current drug therapy, if any: No complaint in the current drug therapy Non-prescribed medication, if any: NSAIDs etc are used by the patient. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Used anti-hypertensive medicines. Do you have any other concurrent ailment / disease? Concurrent CVA. Previous Surgery, if any? (Mention date/ year) Appendix 8 years ago. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) Snuff Smoking
What have you been told about your medicine and by whom? My Consultant told me about medication. Side effects / adverse effects, if any:
Patients Compliance: 1. How do you remember to take your medication? My nurse gives me, my medication. 2. What do you do when you miss a dose? I take at the time when I know. Drug Interactions, if any: Interaction is positive between: Cafotaxime and Furosemide Clarithromycin & Digoxin Hydrocortisone & Digoxin Hadreocortison & Solbutamol Omeprazole & Digoxin. (www.drugs.com)
ADRs /
With the therapy Date wise 1 Ist day 2 Diarrhea + Headche 3 4 5 6 7
Chapter Two Methodology
Page 32
Comments and recommendations (You may attach another sheet): This history is a poly pharmacy due to two antibiotics, cefotaxime & Clarithromycin are prescribed. The narrow therapeutic index drug Digoxin is also prescribed, that can require the TDM and a special care, that is more potent & toxic. There are also 5 drug interactions that can required the special care from the health care professionals. The Clarithromycin and hydrocortisone increase the digoxin blood level and may produce the toxicity of Digoxin. Hydrocortisone and Solbutamol have a miner drug interaction & the interaction b/w Cefotaxime and Furosemide causes the nephrotoxicity, the Furosemide decreases the clearance of cefotaxime and increases the level in the blood. So required the dose monitoring or the therapeutic alternative. So the history is irrational.
Chapter Two Methodology
Page 33
HISTORY# 02 EXPANDED MEDICATION HISTORY/ PATIENT INTERVIEW Patients Name: Tariq Jaan Sex: Male Age: 43 years
Chief Complaints: SOB Dry Cough Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 12/03/2014 Chest x.ray 12/03/2014 RBS 80mg/dl 65-155mg/dl 12/03/2014 Urea 32mg/dl 20-40mg/dl 12/03/2014 Creatanine 0.6mg/dl 0.6-1.3mg/dl
Diagnosis: Bronchial Asthma
Chapter Two Methodology
Page 34
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 12/03/2014 Inj.Astexone- 1gm Cefotaxime OD
12/03/2014 Syp. Epitize Amino Acid (liver tonic) 2TSF x TDS
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: Diarrhea(Due to anti-biotics) Non-prescribed medication, if any: Non-prescribed medication is not used by the patient. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Indication used by the patient is anti-pyratics and anti-asthmetics .
Chapter Two Methodology
Page 35
Do you have any other concurrent ailment / disease? No other disease currently. Previous Surgery, if any? (Mention date/ year) Appendix -5 years ago. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) No social drug.
What have you been told about your medicine and by whom? My physician told me to take medication. Side effects / adverse effects, if any:
Patients Compliance: 1. How do you remember to take your medication? My nurse gives me medication. 2. What do you do when you miss a dose?
With the therapy Date wise 1 Ist day Diarrhea 2 3 4 5 6 7
Chapter Two Methodology
Page 36
I take the next dose. Drug Interactions, if any: No Interations. Comments and recommendations (You may attach another sheet):
This history is according to the complaints of the pt, in this history also the two antibiotics are prescribed so poly pharmacy case & have no drug interactions. There is diarrhea induced by antibiotics, that can be managed by counsel the patient to take medication on empty stomach, beside this the prescription is totally rational.
Chief Complaints: SOB Cough Talklessness Diarrhea Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 17/03/2014 RBS 103mg /dl 65-155 mg/dl 17/03/2014 ECG Normal 17/03/2014 Chest-X ray 17/03/2014 Urea 28mg/dl 20-40 mg/dl 17/03/2014 Creatanine 0.9 mg/dl 0.6-1.3 mg/dl 17/03/2014 Echo RV Diastolic Dysfunction
Diagnosis: Asthma CAD Chapter Two Methodology
Page 38
Prescribed medications (you may attach a separate sheet for complete record date wise): Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 17/03/2014 Inj.Klaricid-500mg in 100ml Pladix Clyrithromycin BiD
18/03/2014 Tab.Norplast-s-75 mg Clopidogril+Aspirin OD
18/03/2014 Tab.Capril-125 mg Captopril OD
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaint. Non-prescribed medication, if any: Non-prescribe medication that is used by the patient is NSAIDs. Chapter Two Methodology
Page 39
Past Medications: No past medication. (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Do you have any other concurrent ailment / disease? No other disease currently. Previous Surgery, if any? (Mention date/ year) Bow l pass surgery, more than 20 years ago. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) Snuff What have you been told about your medicine and by whom? The consultant told me about my medication. Side effects / adverse effects, if any:
Patients Compliance: 1. How do you remember to take your medication? My nurse and children give me, my medication. 2. What do you do when you miss a dose? I take the next dose. Drug Interactions, if any: The following interactions: Clarithromycin & Omeprazole Hydrocortisone & Solbutamol. (www.drugs.com) Comments and recommendations (You may attach another sheet):
This history have no poly pharmacy, the history is according to the complaints of the pt, but still there are two miners interactions b/w Clarithromycin/Omeprazole & Hydrocortisone/Solbutamol that dont have significant adverse effect, but required attention and care from the health care professionals. There is no adverse effect found. To prescribe the therapeutic alternative, that can overcome the drug interactions. The history is counted to be rational, b/c the drug interactions are of miner type.
Chapter Two Methodology
Page 41
HISTORY# 04 EXPANDED MEDICATION HISTORY/ PATIENT INTERVIEW Patients Name: Ameer Zada Sex: Male Age: 85
Address: Baghicha Deri Ward & admission No: A & 1259/267
Chief Complaints: SOB Cough with sputum Body aches Fever Pulse 72/min B.P 120/90 Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 19/03/2014 Echo Normal 19/03/2014 ECG Normal 19/03/2014 Special smear 19/03/2014 ALT 50g/L 42 g/L 19/03/2014 AST 40 g/L 35 g/L
Diagnosis: Known Asthma Acute exacerbation of COPD. Chapter Two Methodology
Page 42
Prescribed medications (you may attach a separate sheet for complete record date wise): Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 19/03/2014 Inj.Klaricid 500mg in 100ml pladix Clyrithromycin BiD
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No Complaints. Non-prescribed medication, if any: No Self medication. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) No past medication. Chapter Two Methodology
Page 43
Do you have any other concurrent ailment / disease? No disease currently. Previous Surgery, if any? (Mention date/ year) No previous surgery. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) Smoking What have you been told about your medicine and by whom? My physician Side effects / adverse effects, if any:
Patients Compliance: 1. How do you remember to take your medication? My nurse gives me, my medication.
2. What do you do when you miss a dose? I take the next dose. Drug Interactions, if any: Interactions between: Cefotaxime and Furosemide Hydrocortisone & Solbutamol. (www.drugs.com) Comments and recommendations (You may attach another sheet):
This history is poly pharmacy b/c the two antibiotics are prescribed. There are 2 interactions b/w hydrocortisone/Solbutamol that is a minor interaction and have no cosequences & the interaction b/w cefotaxime/Furosemide causes the nephrotoxicity, the Furosemide decreases the clearance of cefotaxime in kidney, so increases cefotaxime level and may required dose adjustment. We can overcome the drug interactions by prescribing the therapeutic alternative of the drugs. The prescription is irrational.
Chief Complaints: SOB Dry Cough B.P: 140/90 Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 19/03/2014 RBS 147 mg/dl 65-155mg/dl 19/03/2014 Urea 37 mg/dl 20-40 mg/dl 19/03/2014 Creatanine 1 mg/dl 0.6-1.3mg/dl 19/03/2014 Chest X.ray
Diagnosis: Asthma
Chapter Two Methodology
Page 46
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 19/03/2014 O2 Inhalation-2 liter Pure oxygen Per day
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaints in current therapy Chapter Two Methodology
Page 47
Non-prescribed medication, if any: No self medications.
Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) No past medication used by the patient. Do you have any other concurrent ailment / disease? No other disease currently. Previous Surgery, if any? (Mention date/ year) No past surgery. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) No social is used by the patient.
What have you been told about your medicine and by whom? My physician told me, to take medication regularly
Patients Compliance: 1. How do you remember to take your medication? My nurse told me, and also gives the medication regularly. 2. What do you do when you miss a dose? Then I take the next dose. Drug Interactions, if any: Interactions is between: Hydrocortisone & Solbutamol Dexamethasone & Solbutamol (www.drugs.com) Comments and recommendations (You may attach another sheet):
This is also a poly pharmacy prescription, in this the two corticosteroids is prescribed, that cant improve the pt compliance and also produce the financial problem to the pt. There are two drug interactions of minor type and have no adverse effects, but required a special attention from the health care professionals, to over come this problems by giving the therapeutic alternatives of the drugs. There are two drug interactions of miner type and also have poly pharmacy, so we well count the history as irrational.
ADRs /
With the therapy Date wise 1 Ist day 2 3 4 5 6 7
Chapter Two Methodology
Page 49
HISTORY# 06 EXPANDED MEDICATION HISTORY/ PATIENT INTERVIEW Patients Name: Dil raz Sex: Female Age: 47
Address: Shergarh, Mardan Ward & admissionNo: A & 1260/265
Consultant/ Physician: Dr.Amir khan B. No: Extra bed
Chief Complaints: Chest pain SOB Cough Wheezing Bp: 130/80 Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 19/03/2014 RBS 110 mg/dl 65-155mg/dl 19/03/2014 Chest X ray 19/03/2014 Echo. Normal 19/03/2014 ALT 43g/l 42g/l 19/03/2014 AST 38g/l 35 g/l
Diagnosis: Asthma COPD Chapter Two Methodology
Page 50
LRTi Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 19/03/2014 Ventolin NB Salbutamol QiD
19/03/2014 Atem NB Ipratropium bromide BiD
19/03/2014 Inj.Klaricid-500mg in 100 ml pladix Clyrithromycin BiD
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaint Non-prescribed medication, if any: NSAIDS & Anti-Hypertensive
Chapter Two Methodology
Page 51
Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Anti-hypertensive medications are used by the patient. Do you have any other concurrent ailment / disease? Hypertension Previous Surgery, if any? (Mention date/ year) No previous surgery Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) No social drugs.
What have you been told about your medicine and by whom? My consultant told me. Side effects / adverse effects, if any:
% Response
since date of admission Nil / Improving / Deteriorating Nil / Improving / Deteriorating Nil / Improving / Deteriorating Nil / Improving / Deteriorating Nil / Improving / Deteriorating Nil / Improving / Deteriorating Nil / Improving / Deteriorating Nil / Improving / Deteriorating 1 A little bit feeling good 2 3 4 5 6 7 8
Chapter Two Methodology
Page 52
Patients Compliance: 1. How do you remember to take your medication? My nurse and children. 2. What do you do when you miss a dose? I take at the time, when I know. Drug Interactions, if any: The interaction is b/w: Ceftriaxone & Clarithromycin. (www.drugs.com) Comments and recommendations (You may attach another sheet):
The history is according to the complaints of pt, but the two antibiotics are prescribed thats why the history is poly pharmacy. There is the interaction b/w Ceftriaxone and Clarithromycin. Clarithromycin decreases the clearance of the Ceftriaxone in kidney. By giving the therapeutic alternative or to monitor the dose we can over come this problem. There is no adverse drug reactions but still the history is irrational due, have poly pharmacy and have potent drug interaction.
Chief Complaints: SOB Chest tightness Restlessness Pale color Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 19/03/2014 Urea 40mg/dl 20-40mg/dl 19/03/2014 Creatanine 0.8mg/dl 0.6-1.3mg/dl 19/03/2014 DLC: polys 78% 40-75% 19/03/2014 Chest x.ray
Diagnosis: Asthma Anemia Patient have known hypertensive
Chapter Two Methodology
Page 54
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 19/03/2014 Inj. Astexone-2mg Cefotaxime OD
19/03/2014 Tab.ALP-0.5mg Benzodiazepine OD at night time
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaint in current drug therapy. Chapter Two Methodology
Page 55
Non-prescribed medication, if any: NSAIDs & Anti-hypertensive. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Not related to current illness. Do you have any other concurrent ailment / disease? Hypertension Previous Surgery, if any? (Mention date/ year) No previous surgery Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) Nil
What have you been told about your medicine and by whom? My physician told me about my medication.
Patients Compliance: 1. How do you remember to take your medication? My nurse told me & also gives the medicines. 2. What do you do when you miss a dose? I take the next dose. Drug Interactions, if any: Interactions b/w: Hydrocortisone & Solbutamol Omeprazole & Clarithromycin Benzodiazepine & Clarithromycin Cefotaxime & Furosemide (www.drugs.com)
Comments and recommendations (You may attach another sheet): This prescription is a poly pharmacy due, two antibiotics are prescribed. This history has 4 drug interactions. The two miners b/w hydrocortisone/Solbutamol & Clarithromycin/Omeprazole, these have no adverse effect. The benzodiazepine has interaction with Clarithromycin and required special care. The interaction b/w cefotaxime/Furosemide causes the nephrotoxicity; the Furosemide decreases the clearance of cefotaxime in kidney, so increases cefotaxime level and may required dose adjustment. By giving the therapeutic alternative, we can overcome the problem of drug interactions. The prescription is irrational.
Chief Complaints: SOB Dyspenia High Temp. Dry cough Tachypenia Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 24/03/2014 Echo. L.V. Diastolic dysfunction
24/03/2014 Chest X.ray 24/03/2014 P.smear
Diagnosis: Asthma
Chapter Two Methodology
Page 58
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 24/03/2014 Ventolin NB Solbutamol QiD
24/03/2014 Inj.Rapid-40mg in 100ml pladix Omeprazole + Sodiumbicorbonate OD
24/03/2014 Inj.Klaricid-500mg Clyrithromycin BiD
25/03/2014 Atem NB Ipratropium bromide BiD
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaint in current drug therapy. Non-prescribed medication, if any: No non-prescribed medication is used by the patient.
Chapter Two Methodology
Page 59
Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease). Medication used for the asthma. Do you have any other concurrent ailment / disease? No other disease currently. Previous Surgery, if any? (Mention date/ year) 2 times optic surgery & 3 times DNS. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.)
Nil
What have you been told about your medicine and by whom? My consultant told me, to take medication regularly. Side effects / adverse effects, if any:
Patients Compliance: 1. How do you remember to take your medication? My nurse told me. 2. What do you do when you miss a dose? I take the next dose. Drug Interactions, if any: Interaction b/w: Hydrocortisone/Solbutamol Clarithromycin/Omeprazole (www.drugs.com)
Comments and recommendations (You may attach another sheet):
This history is according to the complaints of the pt, there are two miners drug interactions that are b/w Salbutamol & hydrocortisone, and Clarithromycin & Omeprazole, thats have no serious adverse effect. This pt has no adverse effect records found. By giving the therapeutic alternative we can overcome the problem of drug interactions. The two anti biotics are prescribed, so have poly pharmacy, and the prescription is irrational.
Chief Complaints: SOB Chest pain Cough Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 24/03/2014 Chest pain 24/03/2014 Urea 31mg/dl 20-40mg/dl 24/03/2014 Creatanine 1.0 mg/dl 0.6-1.3mg/dl 24/03/2014 RBS 120mg/dl 65-155mg/dl 24/03/2014 P.smear Normal
Diagnosis: Acute several attack of seasonal bronchial asthma HTN
Chapter Two Methodology
Page 62
Prescribed medications (you may attach a separate sheet for complete record date wise): Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 24/03/2014 Inj.solucortef-250mg Hydrocortisone TDS
24/03/2014 Tab.Deltacortel-5mg Dexamethasone OD
24/03/2014 Tab.Whizix-10mg Montelocast OD
24/03/2014 Cap.Azomax-250mg Azithromycin BiD
24/03/2014 Inh.sertide Xinafoate + Fluticasone propionate 2 puff x Bid
24/03/2014 Telfast -120mg Fexofenasdine OD
25/03/2014 Ventolin NB Salbutamol QiD
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaints. Non-prescribed medication, if any: Non prescribed medication used by the patient is NSAIDs, Antihypertensive & Antiasthmatics. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Chapter Two Methodology
Page 63
For hypertension & Asthma. Do you have any other concurrent ailment / disease? HTN Previous Surgery, if any? (Mention date/ year) No previous surgery record. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) Nill What have you been told about your medicine and by whom? My consultant told me, to take medications. Side effects / adverse effects, if any:
Patients Compliance: 1. How do you remember to take your medication?
My nurse gives me, & also myself. 2. What do you do when you miss a dose? I take the dose at that time when I know. Drug Interactions, if any: Interaction is b/w: Solbutamol & Hydrocortisone (www.drugs.com)
Comments and recommendations (You may attach another sheet):
In this history the physician prescribed the 3 corticosteroids, thats why the history is poly pharmacy. Their also have a miner dreg interaction b/w hydrocortisone & Solbutamol, thats dont have significant effect. There have no adverse effect found. Two mange the drug interaction by giving the therapeutic alternative, or to adjust the dose. The occurrence of the poly pharmacy has a burden on pt, due to medication error and also has financially. This prescription is irrational.
Chapter Two Methodology
Page 65
HISTORY# 10 EXPANDED MEDICATION HISTORY/ PATIENT INTERVIEW Patients Name: Noor ul Huda Sex: Female Age: 45 years
Chief Complaints: SOB Cough Wheezing Chest tightness Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 24/03/2014 RBS 110 mg/dl 65-155mg/dl 24/03/2014 ECG Normal 24/03/2014 Chest X ray 24/03/2014 Urea 44mg/dl 20-40mg/dl 24/03/2014 Creatanine 1.5mg/dl 0.6-1.3mg/dl 24/03/2014 DLC: Polys 78% 40-75%
Diagnosis: Asthma Fever Low grade urethral carcinoma. Chapter Two Methodology
Page 66
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 24/03/2014 Inj.Astexone -2gm Cefotaxime OD
24/03/2014 Syp.Combinol-D 120ml Dextromethorphan HBr Ephedrine Hcl,Amonium 2TSF x TDS
25/03/2014 Inj.Risek-40mg in 100 ml pladix Omeprazole OD
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaint in current drug therapy. Non-prescribed medication, if any: Patient doesnt use the non-prescribed medication.
Past Medications: Chapter Two Methodology
Page 67
(State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Dialysis after every 3 months , since from 1 year. Do you have any other concurrent ailment / disease? Kidney failure. Previous Surgery, if any? (Mention date/ year) The patient has done a surgery. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) No social drugs.
What have you been told about your medicine and by whom? My consultant told me about my medications. Side effects / adverse effects, if any:
Patients Compliance: 1. How do you remember to take your medication? My nurse and my husband give me my medications & also advise to take medication on time. 2. What do you do when you miss a dose? I take the dose at the time when I know. Drug Interactions, if any: Interactions are b/w: Cefotaxime and ferosemide Solbutamol & Dexamethasone (www.drugs.com) Comments and recommendations (You may attach another sheet):
This history is according to the complaints of the pt. this history have no poly pharmacy. There are two interaction b/w cefotaxime/Furosemide causes the nephrotoxicity, the Furosemide decreases the clearance of cefotaxime in kidney, so increases cefotaxime level and may required dose adjustment. The other one is b/w Solbutamol/Dexamethasone that has a miner one. There are no adverse effects recorded. By adjusting the dose or giving the therapeutic alternative, we can overcome the drug interactions. The history is irrational.
Chief Complaints: Chest pain Shortness of breath Wheezing Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 25/03/2014 RBS 125mg/dl 65-155mg/dl 25/03/2014 Urea 35mg/dl 20-40mg/dl 25/03/2014 Creatanine 1.04mg/dl 0.6-1.3mg/dl 25/03/2014 Hbs Ag, HCV Normal 25/03/2014 DLC: polys 82% 40-75% Diagnosis: Asthma COPD
Chapter Two Methodology
Page 70
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 25/03/2014 Inj.Racephin-1gm Ceftriaxone OD Stop on 26/03/14
25/03/2014 Inj.Rapid-40mg in 100 ml padix Omeprazole + sodium bicorbonate OD
25/03/2014 Inj.varen-75mg Diclofenac-Na BiD
25/03/2014 Inj.Decadron-4mg Dexamethasone sodium phosphate TiD
25/03/2014 Syp.Eplyzyme-120ml Digestive enzyme + vitamins 2TSF x TDS
25/03/2014 Tab. ALP-0.5mg Benzodiazepine Once at night
26/03/2014 Inj.Astexone-1gm Cefotaxime BiD
26/03/2014 Inj.Gravinate Dimenhydraminate TDS
26/03/2014 Cap.Caricef-400mg Cefixime trihydrate OD
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: Chapter Two Methodology
Page 71
No complaint. Non-prescribed medication, if any: Self medications are used by the patient. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Medication used for asthma and also NSAIDs. Do you have any other concurrent ailment / disease? No other disease currently. Previous Surgery, if any? (Mention date/ year) Appendix 4 years ago. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) No social drugs.
What have you been told about your medicine and by whom? The doctor told me to take medications.
Side effects / adverse effects, if any: Patients Compliance: 1. How do you remember to take your medication? My nurse gives me my medications. 2. What do you do when you miss a dose? I take the next dose. Drug Interactions, if any: No interactions. Comments and recommendations (You may attach another sheet):
The history is a poly pharmacy. In the prescription at a time more than two antibiotics are prescribed. There are no drug interactions, but have the adverse effect of antibiotics that is diarrhea. To counsel the pt, to take anti biotics before the meal, we can over come this adverse effect, besides this the history is rational.
ADRs /
With the therapy Date wise 1 Ist day 2 Diarrhea 3 4 5 6 7
Chapter Two Methodology
Page 73
HISTORY# 12 EXPANDED MEDICATION HISTORY/ PATIENT INTERVIEW Patients Name: Gul faraz Sex: Male Age: 55 yrs
Chief Complaints: Chest pain SOB Continues cough Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 25/03/2014 RBS 112mg/dl 65-155mg/dl 25/03/2014 Chest X.ray 25/03/2014 Echo. Normal 25/03/2014 DLC: Polys 79% 40-75%
Diagnosis: Asthma COPD LRTi
Chapter Two Methodology
Page 74
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 25/03/2014 Atem NB Ipratropium bromide BiD
25/03/2014 Inj.Klaricid-500mg in 100 ml pladix Clyrithromycin BiD
25/03/2014 Syp.Pulmonol-120ml Chlorpheneramine 2TSF x TDS
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaints in prescribed medication. Non-prescribed medication, if any: Not used by the patients. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Used NSAIDs and Anti-asthmatic medication. Chapter Two Methodology
Page 75
Do you have any other concurrent ailment / disease? No other current illness. Previous Surgery, if any? (Mention date/ year) Optic surgery. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.)
No social drug
What have you been told about your medicine and by whom? My consultant told me, to take medication regularly. Side effects / adverse effects, if any: Patients Compliance: 1. How do you remember to take your medication? My nurse gives me, and also myself I remembered.
With the therapy Date wise 1 Ist day 2 Diarrhea 3 4 5 6 7
Chapter Two Methodology
Page 76
2. What do you do when you miss a dose? I take at that time when I know. Drug Interactions, if any: drug interactions is b/w: Ceftriaxone & Clarithromycin (www.drugs.com) Comments and recommendations (You may attach another sheet):
The history has according to the complaints of pt, but the two antibiotics are prescribed, that is Ceftriaxone & clarithromycin. Have a severe drug interaction of clarithrimycin and Ceftriaxone. It causes the nephrotoxicity by decreases the renal clearance of the ceftriaxone. We can overcome this by giving the therapeutic alternative or adjust the dose. In the adverse effect also have diarrhea due to anti biotics. To take the antibiotics before the meal, the antibiotics induced diarrhea will not be occurs. The history is irrational.
Chapter Two Methodology
Page 77
HISTORY# 13 EXPANDED MEDICATION HISTORY/ PATIENT INTERVIEW Patients Name: Khan Zada Sex: Male Age: 65 years
Chief Complaints: SOB Dry cough Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 26/03/2014 Chest X.ray 26/03/2014 RBS 140mg/dl 65-155mg/dl 26/03/2014 Urea 32mg/dl 20-40mg/dl 26/03/2014 Creatanine 0.9mg/dl 0.6-1.3mg/dl
Diagnosis: Bronchial asthma Bronchial pneumonia
Chapter Two Methodology
Page 78
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 26/03/2014 Inj.Astexone-1mg Cefotaxime OD
26/03/2014 Syp.Epitize-120ml Amino Acid (liver tonic) 2TSF x TDS
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaints in present medication Non-prescribed medication, if any: NSAIDs are used by the patient. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) No past medications. Chapter Two Methodology
Page 79
Do you have any other concurrent ailment / disease? No other disease currently. Previous Surgery, if any? (Mention date/ year) No surgery. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) Snuff
What have you been told about your medicine and by whom? My physician told me. Side effects / adverse effects, if any:
Patients Compliance: 1. How do you remember to take your medication?
2. What do you do when you miss a dose? I take the dose at the time when I know. Drug Interactions, if any: Interaction found b/w: Dexamethasone/Solbutamol (www.drugs.com) Comments and recommendations (You may attach another sheet):
This history is according to the complaints of the pt, but the two antibiotic are prescribed , thats why the history will be counted as poly pharmacy prescription. Interaction is b/w Dexamethasone & Solbutamol, thats had no significant effects but required a little attention from the consultant. There are no adverse effects found in the history. The interaction is miner, but we can manage by giving the therapeutic alternative of the drugs. The history is ratinal, b/c the drug interaction is of miner type.
Chapter Two Methodology
Page 81
HISTORY# 14 EXPANDED MEDICATION HISTORY/ PATIENT INTERVIEW Patients Name: Gul Muhammad Sex: Male Age: 80 yrs
Chief Complaints: SOB Dry Cough Constipation Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 05/04/2014 Chest X-ray 05/04/2014 Sputum AFB 05/04/2014 RBS 110 mg/dl 65-155 mh/dl 05/04/2014 P.Smear
Diagnosis: Bronchial Asthma LRTi
Chapter Two Methodology
Page 82
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 05/04/2014 Inj.Amoxiclave -1.2gm Amoxicillin TDS
06/04/2014 Inj.Aminophylline-250 mg in 500 ml saline Aminophyline BiD
07/04/2014 Tab.BTNO-10 mg Bambuterol-Hcl OD
07/04/2014 Inf.5% Dextrose/Saline Dextrose+Saline OD
07/04/2014 Syp.Coferb-120ml Cough syrup 2TSFxT DS
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: Chapter Two Methodology
Page 83
No complaints in current therapy. Non-prescribed medication, if any: NSAIDs. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) Medication used for Asthma. Do you have any other concurrent ailment / disease? No other disease. Previous Surgery, if any? (Mention date/ year) No past surgery. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) Snuff.
What have you been told about your medicine and by whom? My physician told me.
Patients Compliance: 1. How do you remember to take your medication? My nurse gives me, my medication. 2. What do you do when you miss a dose? I take at the time when I know. Drug Interactions, if any: Interaction is found b/w: Dexamethasone & Solbutamol (www.drugs.com) Comments and recommendations (You may attach another sheet):
This history has a poly pharmacy b/cs prescribed two antibiotics. There one miner drug interaction b/w Dexamethasone and Solbutamol, thats have no significant effect. There has no adverse effect found. We can overcome the interaction by giving the therapeutic alternatives. The interactions is of miner type so the prescriptions rational.
ADRs /
With the therapy Date wise 1 Ist day 2 3 4 5 6 7
Chapter Two Methodology
Page 85
HISTORY# 15 EXPANDED MEDICATION HISTORY/ PATIENT INTERVIEW Patients Name: Salman Khan Sex: Male Age: 42 years
Chief Complaints: SOB High temp. Dry cough with sputum Chills Biochemical tests advised: (mention details; state whether positive or negative.) DATE TEST RESULTS NORMAL RANGE 07/04/2014 Chest X-ray 07/04/2014 Echo R.V Disfunction 07/04/2014 MP Positive 07/04/2014 DLC: Polys 88% 40-75%
Diagnosis: Asthma Malaria
Chapter Two Methodology
Page 86
Prescribed medications (you may attach a separate sheet for complete record date wise):
Date Therapy advised Medicines trade name & strength Generic Name Signa Intervention by physician / Pharmacist 07/04/2014 Ventolin-NB Solbutomol QiD
07/04/2014 Inj.Rapid -40 mg in 100ml pladix Omeprazole+sodium dicarbonate BiD
07/04/2014 Inj.Klaricid Clarithromycin TDS
07/04/2014 Tab.Arti-20/12 mg Artemether+Lumefontrin e TDS for 3 days
08/04/2014 Atem-NB Iprotropium bromide BiD
08/04/2014 Tab.ALP 0.5 mg Benzodiazepine OD at night time
*intervention may be a change in the therapy (either in its dosage forms, doses, type of therapy or addition of another drug(s)) by the respective ward physicians with a clear reason for change to be mentioned in remarks
column. Complaints about current drug therapy, if any: No complaints in present medication Chapter Two Methodology
Page 87
Non-prescribed medication, if any: The patient use NSAIDs and anti-diarrheal agents. Past Medications: (State whether the medication relates to current illness or to any other past disease, In case of past illness, mentions disease) NSAIDs and anti-asthmatic and anti-melonial. Do you have any other concurrent ailment / disease? Malaria. Previous Surgery, if any? (Mention date/ year) No previous surgery. Response to present drug therapy: * Based on % resolution of signs & symptoms or % improvements in patients clinical conditions etc.
Social Drugs, if any: (Like Smoking, Snuff, Alcohol, illicit drugs etc.) Smoking.
What have you been told about your medicine and by whom? My consultant told me to take medication regularly.
Patients Compliance: 1. How do you remember to take your medication? My nurse and wife my medication. 2. What do you do when you miss a dose? I take at that time when I remember.
Drug Interactions, if any: Interactions founds b/w: Clarithromycin & Omeprazole Hydrocortisone & Salbutamol Benzodiazepines & Clarithromycin (www.drugs.com) Comments and recommendations (You may attach another sheet):
This is also a poly pharmacy history due to the prescription of two antibiotics. The pt also has the malaria. There are 3 miners drug interactions, thats have no significant effects and also have no mechanism known. But have required a special attention from the health care professionals. We can overcome the drug interactions by giving the therapeutic alternatives. have no adverse effects found in the history. The prescription is irrational.
ADRs /
With the therapy Date wise 1 Ist day 2 3 4 5 6 7
CHAPTER THREE RESULTS
Chapter Three Results
Page 89
3.1 RESULTS: The data collected was thoroughly evaluated and different problems and irrationalities related to the drug were identified. For evaluation process different standard drug literature and procedure were followed. During this evaluation process the results obtained is presented table wise and also graphically.
PATIENTS DEMOGRAPHIC DATA: Table No. 3.1 patients Demographic Data Characteristics Number of patients Percentage Male 09 60% Female 06 40% All patients 15 100%
Chapter Three Results
Page 90
FIGURE No: 3.1 patient demographic data
60% 40% Patients demographic data Male 09: 60% Female 06: 40% Chapter Three Results
Page 91
AGE WISE DISTRIBUTION OF PATIENTS:
Table No. 3.2 Age wise distribution of patients AGE IN YEARS NO OF PATIENTS PERCENTAGE 30-50 06 40% 51-70 06 40% 71-90 03 20%
FIGURE No: 3.2 Age wise Distribution of patients
Ages of patients
40% 40% 20% 0% 5% 10% 15% 20% 25% 30% 35% 40% 45% 30-50 YEARS (06) 51-70 YEARS (06) 71-90 YEARS (03) AGE WISE DISTRIBUTION OF PATIENTS 30-50 YEARS (06) 51-70 YEARS (06) 71-90 YEARS (03) Chapter Three Results
Page 92
Table # 3.3 drug related problems frequency & percentage wise
Drug related problems Frequency Percentage Untreated condition 05 07.57% Drug without indication 04 06.06% Improper drug selection 00 00.00% Adverse drug reaction 06 09.09% Total drug interaction 28 42.42% Non compliance 00 00.00% Drug required dose adjustment in renal impairment 08 12.12% Therapeutic duplication 01 01.52% Impropriate dosage form 00 00.00% Use of narrow therapeutic index drugs without monitoring 02 03.03% Poly pharmacy 08 12.12% Cost related problems 04 06.06% Total number of drug related problems 66 100%
Chapter Three Results
Page 93
FIGURE No: 3.3 frequency of drug related problems
7.57% 6.06% 0% 9.09% 42.42% 0% 12.12% 1.52% 0% 3.03% 12.12% 6.06% Frequency of drug related problems Untreated condition 05 Drug without indication 04 Improper drug selection 00 Adverse drug reaction 06 Total drug interaction 28 Non compliance 00 Drug required dose adjustment in renal impairment 08 Therapeutic duplication 01 Impropriate dosage form 00 Use of narrow therapeutic index drugs without monitoring 02 Poly pharmacy 08 Cost related problems 04 Chapter Three Results
Page 94
CAUSES OF HOSPITALIZATION: Table No: 3.4 Main Causes Of Hospitalization Main cause of hospitalization Number of patients Percentage SOB 15 100% Cough 05 33.33% Chest pain 05 33.33% Wheezing 03 20.00% Chills 03 20.00%
Figure No: 3.6 Occurrence Of Drug Interaction Per Cent Wise
CHAPTER FOUR DISCUSSION & CONCLUSION
Chapter Four Discussion & Conclusion
Page 98
DISCUSSION & CONCLUSSION
4.1 DISCUSSION After analyzing these fifteen cases, it was noted that the overall prescribed therapy at hospital was of standard nature but there were some short comings which requires proper mutual understandings between health care professionals. There were 60 % male and 40 % female patients in overall fifteen case histories. 33.33 % untreated conditions were left in overall 15 case histories. Most of these conditions were of minor nature like fever, diarrhea and cough but still it needs a therapy, if this condition were not be treated, it were prolonged the hospitalization. 26.67 % drugs were having cost related problems. There are safe, appropriate and cost effective alternatives available which could be prescribed despite of expensive brands. There were 32 % drugs which needed dose correction as the prescribed doses were high and the pt. have renal impairment. Dose calculation has very much importance of the drugs that have narrow therapeutic index or the patient have renal problems. 26.67 % drugs were prescribed without indication, the drug that were prescribed without indication produce some ADRs, drug interactions & also have cost problems to the patients. There was 00 % case with improper drug selection. Adverse drug reaction was detected in 06 cases (40%) of asthma, The patient had taken antibiotics in excessive dose of the drug, if antibiotics were takes before the meal then these drug effects were not be occurs. There was no (00 %) drug which was administered through wrong route. The drug interactions were found in 13 cases out of fifteen that have 86.67%. Some of them have miner interaction but some have potent interactions like Cefotaxime and furosemide, furosemide decreases the renal clearance of the Cefotaxime and causes nephrotoxicity. So this required a special attention from the health care providers. Therapeutic duplications have in one case out of fifteen and have 06.67%, this also increases the cost problems to the patient. In fifteen cases two narrow therapeutic drugs were prescribed, digoxin and aminophylline, and have a percentage of 13.33%, the narrow therapeutics drug required the dose calculation and some special care from the health care providers, to minimize the toxicity and the effects on other drugs. The total drug related problems were 66. If the the health care professionals work in a team, we can overcome these problems. The patient also have to take medication on time, and follow the instruction of the physician to minimize the drug related problems. Chapter Four Discussion & Conclusion
Page 99
4.2 CONCLUSION This clerk ship report is made in Mardan Medical Complex, Mardan, on 15 cases of asthma and have 12 weeks internship. The data together is about the rationality & irrationality of the prescribed medication of asthma. The treatment provided in the hospital was according to the standard protocol however, some drug related problems were detected which include excessive doses, drug-drug interactions, improper drug selection, adverse drug reactions, untreated conditions and cost related problems. Due to maximum number of patients in hospital, lack of proper interaction and Co-operation between health care professionals and burden on physicians, the goal and vision of rational pharmacotherapy is still far away to be achieved. In order to rationalize overall pharmacotherapy of individual patient, professional mutual interaction among physicians, pharmacists and nurses is required. Based on this project report, it is concluded that there is lack of consideration among the physicians regarding the proper dose calculation in Asthmatic medicines. Proper system of dose calculation must be introduced in order to reduce the adverse drug reactions. There were many drug interactions b/w the drugs, that is due to poly pharmacy, improper drug selection, and duplication in dosage form e.g. the drug interactions b/w Clarithromycin and Clarithromycin were observed that is due to poly pharmacy i.e. due to prescription of two antibiotics.
Chapter Four Discussion & Conclusion
Page 100
Table No: 4.1 Drug interactions and consequences
S.No Drug Interactions Consequences
01
Cefotaxime/Furosemide Causes the nephrotoxicity, the Furosemide decreases the clearance of Cefotaxime in kidney, so increases Cefotaxime level and may require dose adjustment
02
Ceftriaxone & Clarithromycin Clarithromycin may affect the function of Ceftriaxone, so required the monitoring
03
Hydrocortisone & Salbutamol Miner interactions, mechanism is unknown
04
Dexamethasone & Salbutamol Miner interactions, mechanism is unknown
The ADRs were also seen due lake of proper patient education and counseling by the physician, e.g. antibiotics induced diarrhea, if antibiotics induced diarrhea then it will be taken on empty stomach then this ADR will not be occurs. The patient education, counseling and information are also important parameter so that patient can be provided with complete pharmaceutical care. Patient must be educated properly in order to increase the compliance level. A proper and computerized channel should be followed while supplying the drugs from hospital pharmacies to the respective wards. Hospital pharmacies are required to be computerized in this regard. Ministry of Health is responsible to provide cost effective drugs to the respective hospitals. Free of cost medicines should be distributed among the needy patients in order to reduce the cost related problems.
REFERENCES
References
Page 101
REFERENCES
BNF for children 2009, Pp.168 British Guidelines on the management of asthma by British Thoracic Society May 2008, revised June 2009, Pp. 2-3 George ronnald B Lippincott William and walkins, 2005, edition 5 th , chest medicines: essential of pulmonary & essential care medicines p-62 http://www.bcguidelines.ca/gpac/guideline_asthma.html#diagnosis [Accessed date: 14/04/2014] http://www.merckmanuals.com/home/sec04/ch042/ch042b.html [Accessed date: 14/04/2014] http://www.lahorerealestate.com/pakrealestatetimes/showthread.php?tid=4741 [Accessed date: 29/04/2014 http:// www.who.int/mediacentre/factsheets/fs307/en/ [Accessed date: 29/04/2014] http://www.who.int/respiratory/asthma/definition/en/ [Accessed date: 10/04/2014] Kelly. W And Christine A. Sorkness, Asthma, Joseph T. DiPiro et al, Pharmacotherapy A Pathophysiologic Approach, 7th Edition, Mc Graw Hill 2008, Pp 464,479 Kelly. W And Christine A. Sorkness, Asthma, Joseph T et al, Pharmacotherapy Handbook, 7th Edition, Mc Graw Hill, 2009, Pp- 906-909 Lippincotts pharmacology by Michelle A. cleck, Rched firrel, et al, 4 th Edition, 2009, Pp 77 Mark S. Chesnutt et al, Lung, Daniel C. Adelman et al, Current Medical Diagnosis & Treatment, 45th Edition, McGraw Hill, 2006, Pp 228-235, Mark S. Chesnutt et al, Lung, Daniel C. Adelman et al,, Current Medical, Diagnosis & Treatment, 45th Edition, McGraw Hill, (2006), Pp 250
Wanis H Ibrahim - Short and OSCE Cases in Internal Medicine - Clinical Exams For PACES, MRCPI, Arab Board and Similar Exams-Jaypee Brothers Medical Publishers (2020)
Evaluation of Doctor's Perception About The Role of The Pharmacy in Pharmaceutical Services in Tengku Rafi'an Siak Hospital and Dr. Rasidin Padang Hospital
International Journal of Innovative Science and Research Technology